Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 11414 participants.

Also called NCT03264352

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 11,414 participants (planned count) (from the registry)
Sponsor
XueQing Yu (from the registry)
Registry
  • NCT NCT03264352
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT03264352. Randomized; single masking; primary purpose treatment. Start 2018-02-01 (actual); primary completion 2028-09-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes
Acronym
IPAD
Condition
Diabetes Mellitus, Type 2
Condition
Adverse Event
Condition
Blood Pressure
Condition
Prehypertension
Condition
Cardiovascular Risk Factor
Intervention (Drug)
Allisartan Isoproxil
Intervention (Drug)
Amlodipine 5mg
Intervention (Other)
Standard treatment by current guideline
Lead sponsor
XueQing Yu (class: other)

Record details

Record id
cardio:ct-nct03264352
Content hash
6802babdd445448fa287b41efdf37a4518704a2fb5d9346b62c0d6fed0248e70